IACS-010759

N/A

Report date: 2025/11/23 20:00:08

Base Information

Drug NameIACS-010759
Drug Alias NameIACS-10759IACS-010759
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionQuinone reductase 1 inhibitors
TargetsQuinone reductase 1
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsTriple Negative Breast Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Texas MD Anderson Cancer Center
Active IndicationsN/A
Inactive IndicationsSolid tumoursPancreatic NeoplasmsTriple Negative Breast Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A